Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chylothorax and sarcoidosis]

M L Carlier1, J P Roux, T Perez

  • 1Service de Pneumo-immuno-allergologie, Hôpital Calmette, CHRU, Lille.

Revue Des Maladies Respiratoires
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From parasites to allergy: a second receptor for IgE.

Immunology today·2014
Same author

[Hypersensitivity pneumonitis in a chicory worker].

Revue des maladies respiratoires·2008
Same author

Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats.

The European respiratory journal·2007
Same author

[Characteristics of mild asthma: clinical signs and medication use. Position statement of the Mild Asthma Working Group (174)].

Revue des maladies respiratoires·2007
Same author

High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.

Neuromuscular disorders : NMD·2006
Same author

[Characteristics of mild asthma: descriptive epidemiology and nature of bronchial inflammation. Position of the Mild Asthma Working Group].

Revue des maladies respiratoires·2006
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Sarcoidosis rarely causes chylothorax. This case highlights how mediastinal sarcoidosis can lead to chylothorax, pleural fibrosis, and worsening restrictive lung disease despite steroid treatment.

Area of Science:

  • Pulmonology
  • Thoracic Medicine
  • Rare Diseases

Background:

  • Sarcoidosis is a multisystem inflammatory disease.
  • Chylothorax, the accumulation of lymphatic fluid in the pleural space, is a rare complication.
  • The association between sarcoidosis and chylothorax is exceptionally uncommon.

Observation:

  • A 64-year-old patient with mediastinal sarcoidosis developed a right chylothorax two years post-diagnosis.
  • Imaging revealed mediastinal lymphadenopathy and right hemithorax retraction, without interstitial lung disease.
  • Pulmonary function tests showed a restrictive defect (FVC 53%, FEV1 54%), worsening over time despite steroid therapy.

Findings:

  • Despite treatment, the patient exhibited ongoing disease activity, including persistent pleural effusion and mediastinal adenopathy.

Related Experiment Videos

  • The restrictive defect significantly worsened (FVC 44%, FEV1 47%).
  • Hemithorax contraction and severe restrictive defect suggested pleural fibrosis and lymphatic pathway compression.

    • Implications:

    • This case underscores the potential for sarcoidosis to cause significant thoracic complications, including chylothorax.
    • It highlights the challenges in managing sarcoidosis-related chylothorax, which may involve pleural fibrosis and lymphatic obstruction.
    • Further research into the mechanisms and optimal management of this rare association is warranted.